Boston Scientific (BSX) Long-Term Deferred Tax (2009 - 2026)

Boston Scientific's Long-Term Deferred Tax history runs 18 years deep, the most recent figure standing at $4.0 billion for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax rose 7.54% year-over-year to $4.0 billion; the TTM figure through Mar 2026 stood at $4.0 billion (up 7.54% YoY), while the FY2025 annual figure was $3.7 billion, up 0.55% from the prior year.
• Long-Term Deferred Tax came in at $4.0 billion for Q1 2026 at Boston Scientific, up from $3.7 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.1 billion in Q1 2022 to a low of $3.7 billion in Q4 2024.
• A 5-year average of $3.8 billion and a median of $3.8 billion in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax dropped 4.92% in 2023 and climbed 7.54% in 2026, its largest moves.
• Boston Scientific's Long-Term Deferred Tax stood at $3.9 billion in 2022, then decreased by 2.56% to $3.8 billion in 2023, then decreased by 4.84% to $3.7 billion in 2024, then gained by 0.55% to $3.7 billion in 2025, then increased by 7.56% to $4.0 billion in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.0 billion, $3.7 billion, and $3.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison